EastPharma Ltd. announced sales results for the first quarter ended 31 March 2016. According to IFRS results, revenue in first quarter of 2016 was USD 63.7 million, up 9.6% from the same period in 2015 of USD 58.1 million. In Turkish Lira terms, revenue increased by 31.2% in the same period (net sales in first quarter of 2016 were TRY 187.4 million against TRY 142.8 million net sales in first quarter of 2015). Company's sales increase was mainly achieved by increased volumes in Deva's Human Pharma products business and veterinary products business.